This page shows Alvotech (ALVO) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Alvotech passes 2 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
For every $1 of reported earnings, Alvotech generates $-1.80 in operating cash flow (-$50.2M OCF vs $27.9M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
Alvotech generated $159.7M in revenue in fiscal year 2025. This represents a decrease of 67.4% from the prior year.
Alvotech reported $27.9M in net income in fiscal year 2025. This represents an increase of 112.0% from the prior year.
Cash & Balance Sheet
Alvotech generated -$114.7M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 60.5% from the prior year.
Alvotech held $172.4M in cash against $138.0M in long-term debt as of fiscal year 2025.
Alvotech had 312M shares outstanding in fiscal year 2025. This represents an increase of 3.4% from the prior year.
Margins & Returns
Alvotech's net profit margin was 17.5% in fiscal year 2025, showing the share of revenue converted to profit. This is up 64.8 percentage points from the prior year.
Capital Allocation
Alvotech invested $64.5M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 20.1% from the prior year.
ALVO Income Statement
| Metric | Q1'26 | Q3'25 | Q1'25 | Q3'24 | Q1'24 | Q3'23 | Q3'22 | Q3'21 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
ALVO Balance Sheet
| Metric | Q1'26 | Q3'25 | Q1'25 | Q3'24 | Q1'24 | Q3'23 | Q3'22 | Q3'21 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.4B+14.0% | $1.2B+14.3% | $1.1B+12.5% | $950.1M+4.3% | $910.7M+9.9% | $828.4M+38.5% | $598.0M | N/A |
| Current Assets | $509.5M+12.0% | $455.0M+59.5% | $285.2M+46.4% | $194.8M-8.1% | $211.9M-8.2% | $230.7M+92.6% | $119.8M | N/A |
| Cash & Equivalents | $151.5M+194.5% | $51.4M+369.9% | $10.9M-1.9% | $11.2M-81.5% | $60.5M-9.0% | $66.4M+278.4% | $17.6M-44.6% | $31.7M |
| Inventory | $155.5M+21.6% | $127.9M+32.4% | $96.6M+29.7% | $74.4M-6.2% | $79.4M+11.0% | $71.5M+83.0% | $39.1M | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | $16.3M-50.5% | $33.0M | N/A | N/A |
| Goodwill | $12.8M+12.9% | $11.3M-3.1% | $11.7M-3.0% | $12.1M+1.4% | $11.9M+2.1% | $11.6M-5.9% | $12.4M-7.9% | $13.4M |
| Total Liabilities | $1.6B-4.2% | $1.6B-2.4% | $1.7B-11.1% | $1.9B+35.5% | $1.4B-0.3% | $1.4B+89.9% | $733.6M | N/A |
| Current Liabilities | $279.7M+44.7% | $193.4M-83.9% | $1.2B+360.8% | $260.9M+17.7% | $221.7M+32.5% | $167.3M+49.6% | $111.8M | N/A |
| Long-Term Debt | $136.3M+21.5% | $112.1M-8.0% | $121.9M+15.4% | $105.6M+20.8% | $87.4M+147.2% | $35.4M-69.2% | $114.8M-79.8% | $567.9M |
| Total Equity | -$173.3M+58.0% | -$412.8M+31.9% | -$605.9M+35.0% | -$932.5M-94.9% | -$478.5M+15.2% | -$564.4M-316.2% | -$135.6M+84.4% | -$867.2M |
| Retained Earnings | -$2.3B+5.8% | -$2.4B-3.3% | -$2.4B-7.0% | -$2.2B-26.7% | -$1.7B-5.3% | -$1.7B-45.0% | -$1.1B | N/A |
ALVO Cash Flow Statement
| Metric | Q1'26 | Q3'25 | Q1'25 | Q3'24 | Q1'24 | Q3'23 | Q3'22 | Q3'21 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
ALVO Financial Ratios
| Metric | Q1'26 | Q3'25 | Q1'25 | Q3'24 | Q1'24 | Q3'23 | Q3'22 | Q3'21 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | 1.82-0.5 | 2.35+2.1 | 0.24-0.5 | 0.75-0.2 | 0.96-0.4 | 1.38+0.3 | 1.07 | N/A |
| Debt-to-Equity | -0.79-0.5 | -0.27-0.1 | -0.20-0.1 | -0.11+0.1 | -0.18-0.1 | -0.06+0.8 | -0.85-0.2 | -0.65 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$284.5M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Similar Companies
Frequently Asked Questions
What is Alvotech's annual revenue?
Alvotech (ALVO) reported $159.7M in total revenue for fiscal year 2025. This represents a -67.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Alvotech's revenue growing?
Alvotech (ALVO) revenue declined by 67.4% year-over-year, from $489.7M to $159.7M in fiscal year 2025.
Is Alvotech profitable?
Yes, Alvotech (ALVO) reported a net income of $27.9M in fiscal year 2025, with a net profit margin of 17.5%.
How much debt does Alvotech have?
As of fiscal year 2025, Alvotech (ALVO) had $172.4M in cash and equivalents against $138.0M in long-term debt.
What is Alvotech's net profit margin?
Alvotech (ALVO) had a net profit margin of 17.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Alvotech's free cash flow?
Alvotech (ALVO) generated -$114.7M in free cash flow during fiscal year 2025. This represents a 60.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Alvotech's operating cash flow?
Alvotech (ALVO) generated -$50.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Alvotech's total assets?
Alvotech (ALVO) had $1.5B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Alvotech's capital expenditures?
Alvotech (ALVO) invested $64.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Alvotech's current ratio?
Alvotech (ALVO) had a current ratio of 1.89 as of fiscal year 2025, which is generally considered healthy.
What is Alvotech's debt-to-equity ratio?
Alvotech (ALVO) had a debt-to-equity ratio of -0.49 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Alvotech's return on assets (ROA)?
Alvotech (ALVO) had a return on assets of 1.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Alvotech's cash runway?
Based on fiscal year 2025 data, Alvotech (ALVO) had $172.4M in cash against an annual operating cash burn of $50.2M. This gives an estimated cash runway of approximately 41 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Alvotech's debt-to-equity ratio negative or unusual?
Alvotech (ALVO) has negative shareholder equity of -$284.5M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Alvotech's Piotroski F-Score?
Alvotech (ALVO) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Alvotech's earnings high quality?
Alvotech (ALVO) has an earnings quality ratio of -1.80x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.